CYC-116
Cat.No:IC1810 Solarbio
CAS:693228-63-6
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
CYC-116CAS:693228-63-6
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
CAS | 693228-63-6 |
Name | CYC-116 |
Molecular Formula | C18H20N6OS |
Molecular Weight | 368.46 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | Light yellow to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD14155805 |
SMILES | CC1=C(SC(N)=N1)C2=NC(NC3=CC=C(C=C3)N4CCOCC4)=NC=C2 |
Target Point | Aurora Kinase |
Passage | Cell Cycle |
Background | CYC-116 is a potent Aurora A/B inhibitor. |
Biological Activity | CYC-116是有效的Aurora A/B 的抑制剂,Ki 值分别为8和9 nM[1]。 |
In Vitro | CYC-116还抑制VEGFR2,Src,Lck和FLT3,其Kis分别为44,82,280,44nM。 CYC-116可具有广谱抗肿瘤活性。 CYC-116显示出对抗癌细胞系的有效抗增殖活性,MCF7,HeLa的IC50分别为0.599,0.59,0.241,0.34,0.725,1.375,0.471,0.034,0.372,0.681,0.151,1.626,0.775,0.308,0.110,0.09,Colo205,HCT-116,HT29,K562,CCRF-CEM,MV4-11,HL60,NCI-H460,A2780,BxPC3,HuPT4,Mia-Paca-2,Saos-2,Messa细胞。用1.25μMCYC-116处理7小时导致HeLa细胞裂解物中组蛋白H3磷酸化的完全抑制[1]。 |
In Vivo | 以75和100mg/kg qd的剂量水平口服施用CYC-116导致肿瘤生长延迟2.3和5.8天,这分别转化为0.32和0.81的特定生长延迟。在研究期间,在两个剂量水平下接受CYC-116的小鼠的平均相对肿瘤体积小于载体处理的小鼠的平均相对肿瘤体积。在100 mg/kg po qd时,生长的减少在第6天和第9天具有统计学意义[1]。 |
Cell Experiment | CYC-116在DMSO中制备并在细胞培养基中稀释[1]。 |
Animal Experiment | 小鼠:用CYC-116处理腹膜内植入P388/0细胞的小鼠,测量抗肿瘤活性作为处理动物与载体对照组的寿命增加[1]。 |
Kinase Experiment | 使用25μL反应体积(25mMβ-甘油磷酸盐,20mM Tris/HCl,pH 7.5,5mM EGTA,1mM DTT,1mM Na 3 VO4,10μg肯普肽(肽底物))进行Aurora A激酶测定,将重组极光A激酶稀释于20mM Tris/HCl,pH8,含有0.5mg/mL BSA,2.5%甘油和0.006%Brij-35。通过加入5μLMg/ ATP混合物(15mMMgCl4,100μMATP,每孔含18.5kBqγ-32P-ATP)开始反应,并在30℃温育30分钟,然后加入25μL终止。 75mM H 3 PO 4。极光B激酶测定如同极光A一样进行,除了在使用之前,极光B在30℃下与内部着丝粒蛋白[1]在单独的反应中活化60分钟。 |
Data Literature Source | [1]. Wang S,et al. Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors. J Med Chem. 2010 Jun 10;53(11):4367-78 |
Unit | Bottle |
Specification | 5mg 10mg |
CYC-116是有效的Aurora A/B 的抑制剂。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.